MAC-5576
MAC-5576 is a SARS-CoV-2 3CL protease inhibitor, with an IC50 of 81 nM. MAC-5576 also inhibits 3CLpro (IC50=0.5 μM), HAV 3Cpro (IC50=0.5 μM), and thrombin (IC50=13 μM) [1][2].
Product Specifications
CAS Number
[219929-01-8]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(C1=CC=CS1)OC2=CC(Cl)=CN=C2
Molecular Formula
C10H6ClNO2S
Molecular Weight
239.68
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Jan E Blanchard, et al. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem Biol. 2004 Oct;11 (10) :1445-53.|[2]Sho Iketani, et al. Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 Apr 1;12 (1) :2016.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-44484/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1880834-01 100 Tests
PE-conjugated Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
Ask
View Details MBS1880834-02 5x 100 Tests
PE-conjugated Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
Ask
View Details 